Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.
Panbela Therapeutics has raised $9.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.
Panbela Therapeutics's investors include Florida Institute for the Commercialization of Florida Technology.
Panbela Therapeutics is headquartered in Minnesota City, United States.
Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.
Panbela Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Panbela Therapeutics — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/panbela-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Panbela Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/panbela-therapeutics
{{cite web |title=Panbela Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/panbela-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Panbela Therapeutics? Request a listing update